WWW.FRO.BE


>> Publication list O-U

THE PURPOSE OF RESEARCH IS TO INCREASE OUR INSIGHT IN FUNCTION AND DYSFUNCTION OF THE VISUAL SYSTEM


List of Papers by Laureates of FRO (Oct 2005) (O t/m U)


RAKIC Jean-Marie

1. Rakic J.M. (1993). Cyclosporin in ophthalmology. Bull. Soc. belge Ophtalmol. 247 (1), 67-70

2. Rakic J.M., Galand A. and Vrensen G.F. (1997). Separation of fibres from the capsule enhances mitotic activity of human lens epithelium. Exp. Eye Res. 64 (1), 67-72

3. Wormstone I.M., Liu C.S., Rakic J.M., Marcantonio J.M., Vrensen G.F. and Duncan G. (1997). Human lens epithelial cell proliferation in a protein-free medium. Invest. Ophthalmol. Vis. Sci. 38 (2), 396-404

4. Van Cauwenberge F., Rakic J.M. and Galand A. (1997). Complicated posterior capsulorhexis: aetiology, management and outcome. Br. J. Ophthalmol. 81 (3), 195-198

5. Massoud H., Comhaire-Poutchinian Y. and Rakic J.M. (1997). Transvitreal endocryoapplication of the ciliary body (French). Bull. Soc. belge Ophtalmol. 267, 177-181

6. Rakic J.M., Galand A. and Vrensen G.F. (2000). Lens epithelial cell proliferation in human posterior capsule opacification specimens. Exp. Eye Res. 71 (5), 489-494

7. Marcantonio J.M., Rakic J.M., Vrensen G.F. and Duncan G. (2000). Lens cell populations studied in human donor capsular bags with implanted intraocular lenses. Invest. Ophthalmol. Vis. Sci. 41 (5), 1130-1141

8. Lambert V., Munaut C., Noel A., Frankenne F., Bajou K., Gerard R., Carmeliet P., Defresne M.P., Foidart J.M. and Rakic J.M. (2001). Influence of plasminogen activator inhibitor type 1 on choroidal neovascularisation. FASEB J. 15 (6), 1021-1027

9. Munaut C., Lambert V., Noel A., Frankenne F., Deprez M., Foidart J.M. and Rakic J.M. (2001). Presence of oestrogen receptor type beta in human retina. Br. J. Ophthalmol. 85 (7), 877-882

10. Lambert V., Munaut C., Jost M., Noel A., Werb Z., Foidart J.M. and Rakic J.M. (2002). Matrix metalloproteinase-9 contributes to choroidal neovascularisation. Am. J. Pathol. 161 (4), 1247-1253

11. Rakic J.M., Lambert V., Munaut C., Bajou K., Peyrollier K., Alvarez-Gonzalez M.L., Carmeliet P., Foidart J.M. and Noel A. (2003). Mice without uPA, tPA or plasminogen genes are resistant to experimental choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (4), 1732-1739

12. Rakic J.M., Lambert V., Deprez M., Foidart J.M., Noel A. and Munaut C. (2003). Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases. Invest. Ophthalmol. Vis. Sci. 44 (4), 1740-1746

13. Rakic J.M., Maillard C., Jost M., Bajou K., Masson V., Devy L., Lambert V., Foidart J.M. and Noel A. (2003). Role of plasminogen activator-plasmin system in tumor angiogenesis (review). Cell. Mol. Life Sci. 60 (3), 463-473

14. Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797

15. Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193

16. Rakic J.M., Zelinkova M., Comhaire-Poutchinian Y., Galand A. and Duchateau E. (2003). Treatment of Graves macular edema with intravitreal injection of corticosteroids (French). Bull. Soc. belge Ophtalmol. 288, 43-48

17. Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noel A. and Rakic J.M. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularisation. FASEB J. 17 (15), 2290-2292

18. Rakic J.M. and Hermans G. (2004). Patient access to the medical file (French). Bull. Soc. belge Ophtalmol. 291, 47-50

19. Blaise P., Duchateau E., Duchesne B., Comhaire Y. and Rakic J.M. (2004). Retinal vascular occlusions: diagnosis and management (French). Rev. Med. Interne. 25 (12), 881-890

20. Rakic J.M., Blaise P. and Foidart J.M. (2005). Pegaptanib and age-related macular degeneration. N. Engl. J. Med. 352 (16), 1720-1721

21. Xhauflaire G., Uhoda E. and Rakic J.M. (2005). Eye and ultraviolet light (French). Rev. Med. Liege. 60 Suppl. 1, 99-102

22. Blaise P., Comhaire Y. and Rakic J.M. (2005). Giant macular hole as an atypical consequence of a toxoplasmic chorioretinitis. Arch. Ophthalmol. 123 (6), 863-864

23. Blaise P., Duchateau E., Comhaire Y. and Rakic J.M. (2005). Improvement of visual acuity after photodynamic therapy for choroidal neovascularization in choroidal osteoma. Acta Ophthalmol. Scand. 83 (4), 515-516

24. Barile S., Van Cauwenberge F. and Rakic J.M. (2005). Diabetic retinopathy (French). Rev. Med. Liege. 60 (5-6), 487-489


ROBE-COLLIGNON Nathalie

1. Collignon-Brach J. and Robe-Collignon N. (2000). Non perforating trabecular surgery with reticulated hyaluronic acid implant (French). Bull. Soc. belge Ophtalmol. 276, 61-68

2. Collignon-Brach J.D., Ravet O. and Robe-Collignon N. (2000). Surgical indications in coexisting cataracts and glaucoma (French) (review). Bull. Soc. belge Ophtalmol. Suppl. 11-36

3. Robe-Collignon N.J. and Collignon-Brach J.D. (2000). Non perforating trabecular surgery with reticulated hyaluronic acid implant (French). Bull. Soc. belge Ophtalmol. Suppl. 45-54

4. Banks M.C., Robe-Collignon N.J., Rizzo J.F. 3rd and Pasquale L.R. (2003). Scanning laser polarimetry of edematous and atrophic optic nerve heads. Arch. Ophthalmol. 121 (4), 484-490


ROZEMA Jos

1. Rozema J.J., Van Dyck D.E.M. and Tassignon M.J. (2005). Clinical comparison of 5 aberrometers (I). Technical specifications. J. Cat. Refract. Surg. 31 (6), 1114-1127

2. Rozema J.J., Van Dyck D.E.M., Pauw M., Van Der Spek B. and Tassignon M.J. (submitted). Clinical comparison of 5 aberrometers (II). Statistical comparison on a test group. J. Cat. Refract. Surg.


STALMANS Ingeborg

1. Vanderschueren A., Stalmans I., Lombaerts R. and Leys A. (1996). Ocular abnormalities in patients with Alport's syndrome. Nephrol. Dial. Transplant. 11 (11), 2355-2358

2. Stalmans I., Buys K., Leys A. and Dralands L. (1997). Spontaneous evolution of stage I and II macular holes. Bull. Soc. belge Ophtalmol. 267, 37-42

3. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., Perriard J.C., Dewerchin M., Flameng W., Nagy A., Lupu F., Moons L., Collen D., D'Amore P.A. and Shima D.T. (1999). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5 (5), 495-502

4. Spiritus A., Dralands L., Stalmans P., Stalmans I. and Spileers W. (2000). OCT study of fellow eyes of macular holes. Bull. Soc. belge Ophtalmol. 275, 81-84

5. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., Di Palma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D. and Persico M.G. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7 (5), 575-583

6. Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., Gardiner T., Hammes H.P., Moons L., Dewerchin M., Collen D., Carmeliet P. and D'Amora P.A. (2002). Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109 (3), 327-336

7. Stalmans P., Van Aken E.H., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285

8. Stalmans I., Lambrechts D., De Smet F., Jansen S., Wang J., Maity S., Kneer P., von der Ohe M., Swillen A., Maes C., Gewillig M., Molin D.G., Hellings P., Boetel T., Haardt M., Compernolle V., Dewerchin M., Plaisance S., Vlietinck R., Emanuel B., Gittenberger-de Groot A.C., Scambler P., Morrow B., Driscol D.A., Moons L., Esguerra C.V., Carmeliet G., Behn-Krappa A., Devriendt K., Collen D., Conway S.J. and Carmeliet P. (2003). VEGF: a modifer of the del22q11 (DiGeorge) syndrome? Nat. Med. 9 (2), 173-182

9. Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236

10. Devriendt K., Swillen A., Stalmans I. and Casteels I. (2005). Pulmonary atresia/ventricular septal defect associated with facial port-wine stain and retinal vascular abnormality: a new constellation or deletion in chromosome 22q11.2? Am. J. Med. Genet. A. 132 (3), 340-341


STALMANS Peter

1. Stalmans P. and Himpens B. (1997). Confocal imaging of Ca2+ signaling in cultured rat retinal pigment epithelial cells during mechanical and pharmacologic stimulation. Invest. Ophthalmol. Vis. Sci. 38 (1), 176-187

2. Stalmans P. and Himpens B. (1997). Effect of increasing glucose and protein phosphorylation on intercellular communication in cultured rat retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 38 (8), 1598-1609

3. Stalmans P., Leys A. and Van Limbergen E. (1997). External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularisation in age-related macular degeneration: a review of 111 cases. Retina. 17 (6), 481-492

4. Stalmans P. and Himpens B. (1998). A decreased Ca2+-wave propagation is found among cultured RPE cells from dystrophic RCS rats. Invest. Ophthalmol. Vis. Sci. 39 (8), 1493-1502

5. D'Hollander F., Stalmans P., Van Libergen E. and Leys A. (1998). Retrospective study on the evolution of visual acuity after external beam radiotherapy (20 Gy, 2 Gy fractions) for subfoveal choroidal neovascular membranes in ARMD. Bull. Soc. belge Ophtalmol. 270, 27-34

6. Himpens B., Stalmans P., Gomez P., Malfait M. and Vereecke J. (1999). Intra- and intercellular Ca2+ signaling in retinal pigment epithelial cells during mechanical stimulation. FASEB J. 13 Suppl., S63-68

7. Stalmans P., Spileers W. and Dralands L. (1999). The use of optical coherence tomography in macular diseases. Bull. Soc. belge Ophtalmol. 272, 15-30

8. Stalmans P., Weckhuysen B., Schoonheydt R., Leys A., Missotten L., Spileers W. and Dralands L. (1999). How to protect your eyes from solar retinopathy. Bull. Soc. belge Ophtalmol. 272, 93-100

9. Stalmans P. and Himpens B. (1999). Properties of intra- and intercellular Ca(2+)-wave propagation elicited by mechanical stimulation in cultured RPE cells. Cell Calcium. 25 (6), 391-399

10. Spaide R.F., Leys A., Herrmann-Delemazure B., Stalmans P., Tittl M., Yannuzzi L.A., Burke K.M., Fisher Y.L., Freund K.B., Guyer D.R., Slakter J.S. and Sorenson J.A. (1999). Radiation-associated choroidal neovasculopathy. Ophthalmol. 106 (12), 2254-2260

11. Leys A., Stalmans P. and Blanckaert J. (2000). Sclerochoroidal calcification with choroidal neovascularisation. Arch. Ophthalmol. 118 (6), 854-857

12. Raus P., Stalmans P., Demeuter E., Spileers W. and Dralands L. (2001). Unusual retinal vasculitis in a patient with protein S deficiency and systemic toxoplasmosis: a case report. Bull. Soc. belge Ophtalmol. 279, 7-12

13. Stalmans P., Parys-Vanginderdeuren R., De Vos R. and Feron E.J. (2001). ICG staining of the inner limiting membrane facilitates its removal during surgery for macular holes and puckers. Bull. Soc. belge Ophtalmol. 281, 21-26

14. Feron E.J., Veckeneer M., Parys-Van Ginderdeuren R., Van Lommel A., Melles G.R. and Stalmans P. (2002). Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch. Ophthalmol. 120 (2), 141-144

15. Stalmans P., Van Aken E.H., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285

16. Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236

17. Stalmans P., Feron E.J., Parys-Van Ginderdeuren R., Van Lommel A., Melles G.R. and Veckeneer M. (2003). Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br. J. Ophthalmol. 87 (6), 713-716

18. Van de Moere A. and Stalmans P. (2003). Anatomical and visual outcome of macular hole surgery with infracyanine green-assisted peeling of the internal limiting membrane, endodrainage and silicone oil tamponade. Am. J. Ophthalmol. 136 (5), 879-887

19. Stalmans P., Van Lommel A. and Parys-Van Ginderdeuren R. (2003). Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathological correlation. Am. J. Ophthalmol. 136 (5), 961-962

20. Teba F.A., Mohr A., Eckardt C., Wong D., Kusaka S., Joondeph B.C., Feron E.J., Stalmans P., Van Overdam K. and Melles G.R. (2003). Trypan blue staining in vitreoretinal surgery. Ophthalmol. 110 (12), 2409-2412

21. van Meurs J.C., ter Averst E., Hofland L.J., van Hagen P.M., Mooy C.M., Baarsma G.S., Kuijpers R.W., Boks T. and Stalmans P. (2004). Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br. J. Ophthalmol. 88 (1), 110-113

22. Kolacny D., Parys-Vanginderdeuren R., Van Lommel A. and Stalmans P. (2005). Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema. Bull. Soc. belge Ophtalmol. 296, 15-23


STANESCU Dinu

1. De Potter P., Stanescu D., Caspers-Velu L. and Hofmans A. (2000). Photo essay: combined hamartoma of the retina and retinal pigment epithelium in Gorlin syndrome. Arch. Ophthalmol. 118 (7), 1004-1005

2. Stanescu D., Bodaghi B., Huong du L.T., Milea D., Goulet-Salmon B., Piette J.C., Le Hoang P. (2003). Pseudotumor cerebri associated with Sjogren's syndrome. Graefes Arch. Clin. Exp. Ophthalmol. 241 (4), 339-342

3. Buono L.M., Foroozan R., Savino P.J., Danesh-Meyer H.V. and Stanescu D. (2003). Posterior ischemic optic neuropathy after hemodialysis. Ophthalmol. 110 (6), 1216-1218

4. Coscas F., Stanescu D., Coscas G. and Soubrane G. (2003). Feeder vessel treatment of choroidal neovascularisation in age-related macular degeneration (French). J. Fr. Ophthalmol. 26 (6), 602-608

5. Stanescu D., Wattenberg S. and Cohen S.Y. (2003). Photodynamic therapy for choroidal neovascularisation secondary to choroidal nervus. Am. J. Ophthalmol. 136 (3), 575-576

6. Tran T.H., Stanescu D., Caspers-Velu L., Rozenberg F., Liesnard C., Gaudric A., Le Hoang P. and Bodaghi B. (2004). Clinical characteristics of acute HSV-2 retinal necrosis (review). Am. J. Ophthalmol. 137 (5), 872-879

7. Grimm C., Wenzel A., Stanescu D., Samardzija M., Hotop S., Groszer M., Naash M., Gassmann M. and Reme C. (2004). Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J. Neurosci. 24 (25), 5651-5658

8. Stanescu D. and Veriter C. (2005). A normal FEV1/VC ratio does not exclude airway obstruction. Respiration. 71 (4), 348-352

9. Diculescu M., Ciocarlan M., Ciocarlan M., Stanescu D., Ciprut T. and Marinescu T. (2005). Predictive factors for pseudocysts and peripancreatic collections in acute pancreatitis. Rom. J. Gastroenterol. 14 (2), 129-134

10. Stanescu D. and Pieters T. (2005). Anorexia nervosa and emphysema. Am. J. Respir. Crit. Care Med. 172 (3), 398-399


You can find this text at FRO
http://www.fro.be

The URL is:
http://www.fro.be/index.php?op=content&id=36